Parkinson drug development halted as Biogen and Denali stop BIIB122 after phase 2b trial failed to slow disease progression.

In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure’s $7 ...

Big Pharma is pouring money into tech-devised treatments, but the verdict is out on whether they’ll actually work.

VANCOUVER, BC / ACCESS Newswire / May 22, 2026 / Redwood AI Corp. (CSE:AIRX)(OTCQB:RDWCF)(Frankfurt:Y0N, WKN: A422EZ) ("Redwood" or the "Company") is pleased to announce that it has entered into a ...

Tempus AI and Bristol Myers Squibb are expanding their collaboration to apply AI analytics and real world data to oncology and neuroscience drug development. The partnership focuses on using Tempus AI ...

Ensitrelvir marks a breakthrough in anti-COVID treatment, paving the way for future defenses against betacoronaviruses.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Scientists at the University of Münster report a major advance in light-powered chemistry for housane molecules on May 20, ...

More than 200 drugs in the pipeline for ALS are stuck in a system that favors big, slow-moving pharmaceutical companies.

Kinentia Biosciences, an East Greenbush firm that does contract drug development and manufacturing, is expanding its ...

Organoids are miniature tissue or organ models formed by stem cells (including pluripotent stem cells, tissue-specific adult ...

There has been much discussion recently about how artificial intelligence and machine learning (AI/ML) will revolutionize pharmaceutical research. Substantial progress has been made in the discovery ...